Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03998202 · ClinicalTrials.gov registry record
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
A clinical trial of Colorectal Cancer and Sarcopenia, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 300
- Enrollment target
- 20
- Study locations
NCT03998202 is a study of Colorectal Cancer and Sarcopenia that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 300 participants, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 4 states.
The verdict
NCT03998202, a study of Colorectal Cancer and Sarcopenia, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.
Conditions Studied
Study Locations (20)
Illinois
- Illinois CancerCare-Bloomington - Bloomington
- Illinois CancerCare-Canton - Canton
- SIH Cancer Institute - Carterville
- John H Stroger Jr Hospital of Cook County - Chicago
- Carle at The Riverfront - Danville
- Cancer Care Specialists of Illinois - Decatur - Decatur
- Crossroads Cancer Center - Effingham
- Illinois CancerCare-Galesburg - Galesburg
- Carle Physician Group - Mattoon/Charleston - Mattoon
- SSM Health Good Samaritan - Mount Vernon
- Carle BroMenn Medical Center - Normal
- Carle Cancer Institute Normal - Normal
- Cancer Care Center of O'Fallon - O'Fallon
Delaware
- Beebe South Coastal Health Campus - Millville
- Helen F Graham Cancer Center - Newark
- Medical Oncology Hematology Consultants PA - Newark
- Beebe Health Campus - Rehoboth Beach
- Christiana Care Health System-Wilmington Hospital - Wilmington
District of Columbia
- MedStar Georgetown University Hospital - Washington D.C.
Georgia
- John B Amos Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03998202
The ClinicalTrials.gov registry entry for NCT03998202 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,510-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (80% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03998202 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Illinois, Delaware, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03998202 about?
NCT03998202 is a clinical study titled "Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer". This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.
What is the current status of trial NCT03998202?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2019-09-23. Estimated completion is 2026-12-31.
What conditions does trial NCT03998202 study?
This clinical trial studies the following conditions: Colorectal Cancer, Sarcopenia.
Who is sponsoring clinical trial NCT03998202?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03998202 being conducted?
This trial has 20 study locations across Delaware, District of Columbia, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.